COLL FY 2023 Earnings — Collegium Pharmaceutical, Inc. Revenue & Financial Results | Market Cap Arena

COLLCollegium Pharmaceutical, Inc.

$1B

FY 2023 Earnings

Healthcare Drug Manufacturers - Specialty & Generic

Income Statement

Revenue

$567M+22.2% YoY

Gross Profit

$326M57.5% margin

Operating Income

$167M29.5% margin

Net Income

$48M8.5% margin

EPS (Diluted)

$1.29

Cash Flow

Operating Cash Flow

$275M

Free Cash Flow

$274M

Stock-Based Comp.

$27M

Balance Sheet

Total Assets

$1.1B

Total Liabilities

$948M

Stockholders' Equity

$195M

Cash & Equivalents

$239M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$567M	$464M	+22.2%
Gross Profit	$326M	$209M	+55.7%
Operating Income	$167M	$33M	+401.1%
Net Income	$48M	-$25M	+292.6%